- Home
- Insider Trading Stock Activity
- Garg Pushkal
Stock Insider Trading Activity of Garg Pushkal
EVP Chief R&D
Avg Cost/Share
$452.05
Shares
3,022
Total Value
$1,364,387.18
Owned After
20,221
EVP Chief R&D
Avg Cost/Share
$452.32
Shares
2,937
Total Value
$1,327,674.71
Owned After
20,221
EVP Chief R&D
Avg Cost/Share
$458.88
Shares
1,455
Total Value
$666,987.16
Owned After
20,221
EVP Chief R&D
Avg Cost/Share
$452.31
Shares
1,396
Total Value
$632,758.71
Owned After
20,221
CMO & EVP Dev & Med Affairs
Avg Cost/Share
$292.50
Shares
9,766
Total Value
$2,864,985.00
Owned After
20,221
CMO & EVP Dev & Med Affairs
Avg Cost/Share
$243.92
Shares
2,557
Total Value
$621,150.40
Owned After
20,221
CMO & EVP Dev & Med Affairs
Avg Cost/Share
$240.70
Shares
935
Total Value
$225,976.83
Owned After
20,221
CMO & EVP Dev & Med Affairs
Avg Cost/Share
$256.84
Shares
3,109
Total Value
$787,904.15
Owned After
20,221
CMO & EVP Dev & Med Affairs
Avg Cost/Share
$285.00
Shares
52,592
Total Value
$14,988,720.00
Owned After
20,221
SEC Form 4
CMO & EVP Dev & Med Affairs
Avg Cost/Share
$251.62
Shares
1,752
Total Value
$439,759.94
Owned After
20,221
CMO & EVP Dev & Med Affairs
Avg Cost/Share
$250.35
Shares
1,682
Total Value
$422,144.31
Owned After
20,221
CMO & EVP Dev & Med Affairs
Avg Cost/Share
$229.42
Shares
2,103
Total Value
$485,773.38
Owned After
20,221
CMO & EVP Dev & Med Affairs
Avg Cost/Share
$156.35
Shares
574
Total Value
$89,144.57
Owned After
20,221
CMO & EVP Dev & Med Affairs
Avg Cost/Share
$148.26
Shares
1,308
Total Value
$193,665.96
Owned After
20,221
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Garg Pushkal | ALNY | EVP Chief R&D | Oct 3, 2025 | Sell | $452.05 | 3,022 | $1,364,387.18 | 20,221 | |
| Garg Pushkal | ALNY | EVP Chief R&D | Oct 2, 2025 | Sell | $452.32 | 2,937 | $1,327,674.71 | 20,221 | |
| Garg Pushkal | ALNY | EVP Chief R&D | Aug 19, 2025 | Sell | $458.88 | 1,455 | $666,987.16 | 20,221 | |
| Garg Pushkal | ALNY | EVP Chief R&D | Aug 18, 2025 | Sell | $452.31 | 1,396 | $632,758.71 | 20,221 | |
| Garg Pushkal | ALNY | CMO & EVP Dev & Med Affairs | Mar 21, 2025 | Sell | $292.50 | 9,766 | $2,864,985.00 | 20,221 | |
| Garg Pushkal | ALNY | CMO & EVP Dev & Med Affairs | Mar 3, 2025 | Sell | $243.92 | 2,557 | $621,150.40 | 20,221 | |
| Garg Pushkal | ALNY | CMO & EVP Dev & Med Affairs | Feb 27, 2025 | Sell | $240.70 | 935 | $225,976.83 | 20,221 | |
| Garg Pushkal | ALNY | CMO & EVP Dev & Med Affairs | Feb 13, 2025 | Sell | $256.84 | 3,109 | $787,904.15 | 20,221 | |
| Garg Pushkal | ALNY | CMO & EVP Dev & Med Affairs | Jan 27, 2025 | Sell | $285.00 | 52,592 | $14,988,720.00 | 20,221 | |
| Garg Pushkal | ALNY | CMO & EVP Dev & Med Affairs | Dec 12, 2024 | Sell | $251.62 | 1,752 | $439,759.94 | 20,221 | |
| Garg Pushkal | ALNY | CMO & EVP Dev & Med Affairs | Nov 25, 2024 | Sell | $250.35 | 1,682 | $422,144.31 | 20,221 | |
| Garg Pushkal | ALNY | CMO & EVP Dev & Med Affairs | Jun 24, 2024 | Sell | $229.42 | 2,103 | $485,773.38 | 20,221 | |
| Garg Pushkal | ALNY | CMO & EVP Dev & Med Affairs | Feb 27, 2024 | Sell | $156.35 | 574 | $89,144.57 | 20,221 | |
| Garg Pushkal | ALNY | CMO & EVP Dev & Med Affairs | Feb 15, 2024 | Sell | $148.26 | 1,308 | $193,665.96 | 20,221 |